Approval for modification to the formulation, syringe material, specifications, manufacturing process and labeling to support the addition of the lidocaine and improve manufacturing efficacy. the device as modified will be marketed under the trade name,radiesse (+) and is indicated for sub-dermal implantation the correction of moderate to severe facial folds and wrinkles, including nasolabial folds.